PBIO Financial Facts
Net loss applicable to common shareholders: -945.21KGrant revenue: 34.39K
See Full Income Statement
Convertible preferred stock: 100
Deferred revenue: 270.1K
See Full Balance Sheet
Pressure BioSciences, Inc. (PBIO) Earnings
|
Expand Research on PBIO
| Next EPS Date | 8/26/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/21/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/25/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/26/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/25/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/18/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |


